Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glanzmann's Disease”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Testing effectiveness (Phase 2)Looking for participantsNCT07136857
What this trial is testing

Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)

Who this might be right for
Glanzmann Thrombasthenia
Emory University 6
Testing effectiveness (Phase 2)Study completedNCT00774397
What this trial is testing

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 719
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Testing effectiveness (Phase 2)Study completedNCT02332707
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 443
Testing effectiveness (Phase 2)Study completedNCT02133131
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 143
Not applicableWithdrawnNCT02943616
What this trial is testing

ABSORB Post-Approval Clinical Study

Who this might be right for
Ischemic Heart Disease
Abbott Medical Devices
Not applicableLooking for participantsNCT04119908
What this trial is testing

Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases

Who this might be right for
Von Willebrand DiseasesGlanzmann Thrombasthenia
University Hospital, Lille 400
Large-scale testing (Phase 3)UnknownNCT01457937
What this trial is testing

Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)

Who this might be right for
Chronic Hepatitis CMenopause
University of Modena and Reggio Emilia 240
Not applicableLooking for participantsNCT00230165
What this trial is testing

The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.

Who this might be right for
Glanzmann Thrombasthenia
Rockefeller University 60
Large-scale testing (Phase 3)Ended earlyNCT02504099
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 3
Not applicableStudy completedNCT05315232
What this trial is testing

The Experiences of People Who Live With Glanzmanns Thrombasthenia.

Who this might be right for
Glanzmann Thrombasthenia
Haemnet 122
Testing effectiveness (Phase 2)Study completedNCT01054729
What this trial is testing

Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients

Who this might be right for
Hepatitis C
Gilead Sciences 64
Testing effectiveness (Phase 2)Study completedNCT02868242
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 19
Large-scale testing (Phase 3)Study completedNCT02358044
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 257
Not applicableStudy completedNCT04595617
What this trial is testing

Anti-αIIbβ3 Immunization in Glanzmann Thrombasthenia: Prevalence and Associated Risk Factors: Thrombasthenia Anti-αIIbβ3 Antibodies Study (TAAS)

Who this might be right for
Glanzmann Thrombasthenia
University Hospital, Bordeaux 28
Not applicableStudy completedNCT01876745
What this trial is testing

Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan

Who this might be right for
Congenital Bleeding DisorderGlanzmann's Disease
Novo Nordisk A/S 4
Not applicableStudy completedNCT00697320
What this trial is testing

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

Who this might be right for
Congenital Bleeding DisorderCongenital FVII DeficiencyGlanzmann's Disease+2 more
Novo Nordisk A/S 64
Large-scale testing (Phase 3)Study completedNCT03092375
What this trial is testing

Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

Who this might be right for
Hepatitis CHCV
University of Florida 177
Large-scale testing (Phase 3)Study completedNCT02446717
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV+1 more
AbbVie 141
Not applicableNot Yet RecruitingNCT06204042
What this trial is testing

Multinational Glanzmann Study

Who this might be right for
Glanzmann Thrombasthenia
UMC Utrecht 200
Load More Results